Alpha Registry
Claim a profile

Person profile

Public information reviewed

David Kirn

Role

President and Chief Executive Officer at 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT)

Board role

Director, President and Chief Executive Officer · 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT)

4D Molecular Therapeutics, Inc. (NASDAQ: FDMT)

Director, President and Chief Executive Officer · Current mandate

Board Director · Us Listed
FollowSave PDF
More
Reports & analysisAlpha Eval
Public sources
1 reviewed
Profile ownership
Not yet claimed
Last reviewed
Sep 6, 2026
View sources

Agent View

Machine representations

Inspect the same governed public record as Markdown, structured data, or a retrieval endpoint.

Canonical entity
alpha:person:david-kirn
Schema
alpha.governance.entity.public.v1
Last reviewed
2026-09-06T06:32:22.234968+00:00
Verification
source_reported
Ownership
unclaimed

Markdown

https://registry.alpha.ac/people/david-kirn.md
Open Markdown

David Kirn

Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

Record

FieldValue
Representationalpha-profile-markdown-v3
ProtocolAlpha Governance Facts Protocol 0.1
Schemaalpha.governance.entity.public.v1
Record versionpublic-0
Canonical entityalpha:person:david-kirn
Entity typePerson
Canonical URLhttps://registry.alpha.ac/people/david-kirn
PublicationPUBLISHED
Verificationsource_reported
Verification schemaalpha-verification-states-v1
Ownershipunclaimed
Published claims4
Claims under review0
Evidence records1
Conflicts0
Conflicts in internal review0
Observed2026-09-08T16:37:55.448929+00:00
Last reviewed2026-09-06T06:32:22.234968+00:00

Identity

  • Legal name: David Kirn
  • Display name: David Kirn

Leadership

  • PUBLISHED

Roles

  • President and Chief Executive Officer at 4D Molecular Therapeutics, Inc.. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:person:david-kirn:1.
  • Director, President and Chief Executive Officer at 4D Molecular Therapeutics, Inc.. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:person:david-kirn:1.

Governance

  • PUBLISHED

Board committees

  • PUBLISHED

Board membership

  • Serves on the board of 4D Molecular Therapeutics, Inc.. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:person:david-kirn:1.

Executive title

  • Executive title: President and Chief Executive Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:person:david-kirn:1.

Coverage states

FieldValue
IdentityPUBLISHED
BusinessNOT_APPLICABLE
LeadershipPUBLISHED
Board and committeesPUBLISHED
GovernancePUBLISHED
FinancialsNOT_APPLICABLE
WorkforceNOT_APPLICABLE
OwnershipNOT_APPLICABLE
RatingsNOT_PUBLISHED
Market and index contextNOT_APPLICABLE

Public sources

Rights

FieldValue
public_retrievalallowed
agent_retrievalallowed
redistributionnot_granted
model_trainingnot_granted
commercial_usenot_specified
relationship_pathfindingnot_granted
direct_contactnot_granted

Limitations

  • Only permissioned public claims and evidence are included.
  • Absence of a claim is not evidence that the underlying fact is false.
  • Public retrieval does not grant model-training or redistribution rights.
  • Private relationships and Council activity are excluded.

Alternate representations